Icon

CLARINEX-D 12 HOUR (nda021313)- (2.5MG;120MG)

DESLORATADINE; PSEUDOEPHEDRINE SULFATE ORGANON LLC
2.5MG;120MG
Yes Yes
2021-Jun-19 Expired
None None
None No
CLARINEX-D® 12 HOUR Extended Release Tablets is indicated for the relief of nasal and non-nasal symptoms of seasonal allergic rhinitis including nasal congestion, in adults and children 12 years of age and older. CLARINEX-D® 12 HOUR Extended Release Tablets should be administered when the antihistaminic properties of desloratadine and the nasal decongestant activity of pseudoephedrine are desired.
0 0 0
Total Other Developers None
Drugs with Suitability No
2.5MG;120MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.